Our findings suggest that eccDNAs induced by intrinsic DNA damage can activate STING signalling in cancer cells, which offers insights into why some DLBCL patients are prone to disease recurrence with the R‐CHOP strategy. The gene discussed is STING1; the disease is cancer.